Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.20.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues:    
Total revenues $ 14,670 $ 15,583
Costs and operating expenses:    
Cost of product revenue 2,541 4,391
Research and development 10,967 8,016
Selling, general and administrative 8,989 8,415
Total costs and operating expenses 22,497 20,822
Loss from operations (7,827) (5,239)
Interest income 266 231
Other expenses, net (86) (125)
Loss before income taxes (7,647) (5,133)
Provision for income taxes 5 3
Net loss $ (7,652) $ (5,136)
Net loss per share, basic and diluted (usd per share) $ (0.13) $ (0.09)
Weighted average common stock shares used in computing net loss per share, basic and diluted (shares) 58,888 54,170
Product Sales [Member]    
Revenues:    
Total revenues $ 5,100 $ 7,988
Research and Development Revenue [Member]    
Revenues:    
Total revenues $ 9,570 $ 7,595